What is Sangamo Therapeutics Inc (SGMO) stock price today?

Sangamo Therapeutics Inc (SGMO) currently trades at $0.12 per share. The stock has a market capitalization of $78.75M and a P/E ratio of —x.

Is SGMO stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Sangamo Therapeutics Inc has a Smart Value Score of 30/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Sangamo Therapeutics Inc's revenue and earnings?

Sangamo Therapeutics Inc has trailing twelve-month (TTM) revenue of $39.55M with profit margins of 0.00%. Earnings per share (EPS) is $-0.44.

SGMO

Sangamo Therapeutics Inc

NASDAQ: SGMO · HEALTHCARE · BIOTECHNOLOGY

$0.12

-10.24% today

Updated 2026-04-30

Market cap

$78.75M

P/E ratio

—

P/S ratio

1.99x

EPS (TTM)

$-0.44

Dividend yield

—

52W range

$0 – $1

Volume

7.8M

Market cap

$78.75M

P/E ratio

—

P/S ratio

1.99x

EPS (TTM)

$-0.44

Dividend yield

—

52W range

$0 – $1

Volume

7.8M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$3.75

+3045.97%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy2 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 88.40% QoQ

Risks

- Thin margins at 0.00%

- Negative free cash flow $-24.42M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$111.30M	$176.23M	$57.80M	$39.55M	$39.55M
Net income	$-192.28M	$-257.83M	$-97.94M	$-122.93M	$-37.42M
EPS	—	—	—	—	$-0.44
Free cash flow	$-243.80M	$-246.00M	$-67.41M	$-97.31M	$-24.42M
Profit margin	-172.76%	-146.30%	-169.45%	-310.81%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
SGMO	$78.75M	30	5.3	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Sangamo Therapeutics Inc trades at $0.12. Our Smart Value Score of 30/100 indicates the stock is weak. TTM revenue stands at $39.55M.

Frequently asked questions

What is Sangamo Therapeutics Inc's stock price?

Sangamo Therapeutics Inc (SGMO) trades at $0.12.

Is Sangamo Therapeutics Inc overvalued?

Smart Value Score 30/100 (Grade F, Strong Sell).

What is the price target of Sangamo Therapeutics Inc (SGMO)?

The analyst target price is $3.75, representing +3046.0% upside from the current price of $0.12.

What is Sangamo Therapeutics Inc's revenue?

TTM revenue is $39.55M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio1.99x

ROE-2,892.00%

Beta1.50

50D MA$0.34

200D MA$0.47

Shares out0.41B

Float0.41B

Short ratio—

Avg volume7.8M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

SGMO vs LLY →SGMO vs JNJ →SGMO vs ABBV →Stock screener →